<qa>  What is a measurable disease defined as?- patient on the dose-escalation portion of the trial must have evaluable disease, defined as either measurable by RECIST or non-measurable disease e.g. bone mets, pleural effusion or lymphangitic spread. Measurable disease is required for patients in the expanded RP2D cohort. 